BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10937284)

  • 1. Emerging targeting concepts membrane-associated protein thiol-disulfide interchange activity: a potential target for anti-viral and anti-tumor drug design.
    Shen WC
    J Drug Target; 1999; 6(6):387-9. PubMed ID: 10937284
    [No Abstract]   [Full Text] [Related]  

  • 2. Interchangeable modules in bacterial thiol-disulfide exchange pathways.
    Kouwen TR; van Dijl JM
    Trends Microbiol; 2009 Jan; 17(1):6-12. PubMed ID: 19059781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric disulfide bonds.
    Schmidt B; Ho L; Hogg PJ
    Biochemistry; 2006 Jun; 45(24):7429-33. PubMed ID: 16768438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
    Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cysteine residues of biomolecules: new approaches for the design of antiviral and anticancer drugs.
    Scozzafava A; Casini A; Supuran CT
    Curr Med Chem; 2002 Jun; 9(12):1167-85. PubMed ID: 12052170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General method to identify and enrich vicinal thiol proteins present in intact cells in the oxidized, disulfide state.
    Gitler C; Zarmi B; Kalef E
    Anal Biochem; 1997 Oct; 252(1):48-55. PubMed ID: 9324940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper (II) ions affect Escherichia coli membrane vesicles' SH-groups and a disulfide-dithiol interchange between membrane proteins.
    Kirakosyan G; Trchounian K; Vardanyan Z; Trchounian A
    Cell Biochem Biophys; 2008; 51(1):45-50. PubMed ID: 18458828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semisynthetic maytansine analogues for the targeted treatment of cancer.
    Widdison WC; Wilhelm SD; Cavanagh EE; Whiteman KR; Leece BA; Kovtun Y; Goldmacher VS; Xie H; Steeves RM; Lutz RJ; Zhao R; Wang L; Blättler WA; Chari RV
    J Med Chem; 2006 Jul; 49(14):4392-408. PubMed ID: 16821799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions with potential rubber closure extractables. Identification of thiol-disulfide exchange reaction products of captopril and thiurams.
    Corredor C; Tomasella FP; Young J
    J Chromatogr A; 2009 Jan; 1216(1):43-8. PubMed ID: 19041978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatic thiol pKa effects on the folding rate of a disulfide containing protein.
    Gough JD; Gargano JM; Donofrio AE; Lees WJ
    Biochemistry; 2003 Oct; 42(40):11787-97. PubMed ID: 14529290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of a thiolate-quinone charge transfer complex and its adduct form in de novo disulfide bond generation by DsbB.
    Inaba K; Takahashi YH; Ito K; Hayashi S
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):287-92. PubMed ID: 16384917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of disulfide bridging.
    Swaisgood HE
    Biotechnol Adv; 2005 Jan; 23(1):71-3. PubMed ID: 15610967
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of crystallography to the design of antiviral agents.
    Rossmann MG; McKinlay MA
    Infect Agents Dis; 1992 Feb; 1(1):3-10. PubMed ID: 1365526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-glutathionylation in human platelets by a thiol-disulfide exchange-independent mechanism.
    Dalle-Donne I; Giustarini D; Colombo R; Milzani A; Rossi R
    Free Radic Biol Med; 2005 Jun; 38(11):1501-10. PubMed ID: 15890624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modified nucleoside phosphates as precursors of antineoplastic and antiviral compounds in a cell].
    Arzumanov AA; Diatkina NB
    Bioorg Khim; 1996; 22(10-11):777-94. PubMed ID: 9036839
    [No Abstract]   [Full Text] [Related]  

  • 17. Disulfide and multisulfide antitumor agents and their modes of action.
    Lee SH
    Arch Pharm Res; 2009 Mar; 32(3):299-315. PubMed ID: 19387571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of aminoadamantane derivatives for in vitro anti-HIV and antitumor activities.
    da Settimo A; Marini AM; Primofiore G; Da Settimo F
    Farmaco; 1995 May; 50(5):321-6. PubMed ID: 7626166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibly stable thiopolyplexes for intracellular delivery of genes.
    Cavallaro G; Campisi M; Licciardi M; Ogris M; Giammona G
    J Control Release; 2006 Oct; 115(3):322-34. PubMed ID: 17028038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design for potentially anti-tumor and/or anti-viral nucleosides.
    Ohrui H; Waga T; Miyakawa I; Ueno A; Meguro H
    Nucleic Acids Symp Ser; 1993; (29):93-4. PubMed ID: 8247810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.